Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart. This innovative approach helps overcome the typical challenges linked to traditional pacing leads, including complex insertion, inadvertent nerve activation, displacement, removal procedures, and subsequent adjustments. Established in 2003, the company operates out of Sunnyvale, California.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is overpriced on P/FCF.
Target Price
The average target price of EBR.AX is 1.11 and suggests 693% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc